MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD BDRX 深 沪
交易中 08-28 11:10:06 美东时间
0.8549
-0.045
-5.01%
华盛通- 最 高0.88
- 今 开0.87
- 成交量 8.01万股
- 最 低 0.8351
- 昨 收 0.90
- 总市值 87.97万
- 52周最高 59.40
- 市盈率 静 --
- 换手率 7.78%
- 52周最低 0.8351
- 委 比 -50.00%
- 总股本 102.91万
- 历史最高 797088271.056
- 量 比 0.10
- 振 幅 4.99%
- 历史最低 0.8351
- 每 手 1
- 风险率 12.85%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Pre-Bell Movers | WVVIP Ascends Rapidly by 138.7%; Here Are 20 Stocks Moving Premarket (Aug 26)
U.S. stock futures mixed ahead of key inflation data and Nvidia earnings, with pre-market surges in Willamette Valley Vineyards and Cid Holdco contrasting with drops in Intuit and Zoom.
08-26 17:04
美股夜盘 | 大自然药业涨187.16%，Decoy Therapeutics Inc.涨20.51%
LiveWire涨-10.87%；Pyxis Tankers, Inc.涨-9.05%；Cybin, Inc.涨-8.95%
06-29 08:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Cellectar Biosciences (NASDAQ:CLRB) stock moved upwards by 45.0% to $4...
05-05 20:06
美股夜盘 | Mawson Infrastructure Group Inc涨40.15%，Organogenesis Holdings, Inc. Class A涨29.46%
Mawson Infrastructure Group Inc涨40.15%；Organogenesis Holdings, Inc. Class A涨29.46%；Alignment Healthcare, Inc.涨15.85%
04-07 15:01
美股夜盘 | Mawson Infrastructure Group Inc涨42.86%，Organogenesis Holdings, Inc. Class A涨20.54%
Mawson Infrastructure Group Inc涨42.86%；Organogenesis Holdings, Inc. Class A涨20.54%；Alignment Healthcare, Inc.涨15.85%
04-07 13:01
美股夜盘 | Mawson Infrastructure Group Inc涨36.29%，Organogenesis Holdings, Inc. Class A涨23.21%
Mawson Infrastructure Group Inc涨36.29%；Organogenesis Holdings, Inc. Class A涨23.21%；Alignment Healthcare, Inc.涨15.85%
04-07 09:01
Why Is Biodexa Pharmaceuticals (BDRX) Stock Skyrocketing Today?
Biodexa Pharmaceuticals shares are trading sharply higher Thursday afternoon after the company said it partnered with Syngene International.
04-03 01:15
Biodexa Pharma Partners With Syngene International To Manufacture Both MTX240 Active Pharmaceutical Ingredient And Dosage Form
Biodexa Announces Partnership with SyngeneTo Manufacture MTX240 GMP Clinical Trial SuppliesBiodexa Pharmaceuticals PLC (NASDAQ:BDRX) ("Biodexa" or "Company"), a clinical stage biopharmaceutical company developing a
04-02 20:37
